Summary
Vaginal atrophy, also known as urogenital atrophy or atrophic vaginitis, is the inflammation of the vagina. It is the result of the vaginal tissues getting shrunken and thinned out. The most common cause of vaginal atrophy is the lack of estrogen, the female reproductive hormone. Vaginal atrophy can be caused during perimenopause and can get aggravated in the postmenopausal phase.
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
Raw Materials
Cost
Technology
Consumer Preference
Industry Overall:
History
Development & Trend
Market Competition
Trade Overview
Policy
Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):
Regional Market
Production Development
Sales
Regional Trade
Regional Forecast
Company (Allergan, Pfizer, Shionogi, Novo Nordisk, Bayer., Bayer. etc.):
Company Profile
Product & Service
Business Operation Data
Market Share
Investment Analysis:
Market Features
Investment Opportunity
Investment Calculation
Part 1 Industry Overview
1.1 Postmenopausal Vaginal Atrophy Treatment Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
Part 2 Industry Overall
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
Part 3 Postmenopausal Vaginal Atrophy Treatment Market by Product
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 Key Companies List
4.1 Allergan (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Pfizer (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 Shionogi (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 Novo Nordisk (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 Bayer. (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 Bayer. (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
Part 5 Market Competition
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
Part 6 Market Demand by Segment
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
Part 7 Region Operation
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
Part 8 Market Investment
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
Part 9 Conclusion
Table Global Postmenopausal Vaginal Atrophy Treatment Market 2012-2017, by Type, in USD Million
Table Global Postmenopausal Vaginal Atrophy Treatment Market 2012-2017, by Type, in Volume
Table Global Postmenopausal Vaginal Atrophy Treatment Market Forecast 2018-2023, by Type, in USD Million
Table Global Postmenopausal Vaginal Atrophy Treatment Market Forecast 2018-2023, by Type, in Volume
Table Allergan Overview List
Table Postmenopausal Vaginal Atrophy Treatment Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Postmenopausal Vaginal Atrophy Treatment Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Shionogi Overview List
Table Postmenopausal Vaginal Atrophy Treatment Business Operation of Shionogi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novo Nordisk Overview List
Table Postmenopausal Vaginal Atrophy Treatment Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer. Overview List
Table Postmenopausal Vaginal Atrophy Treatment Business Operation of Bayer. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer. Overview List
Table Postmenopausal Vaginal Atrophy Treatment Business Operation of Bayer. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Postmenopausal Vaginal Atrophy Treatment Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Postmenopausal Vaginal Atrophy Treatment Sales Revenue Share, by Companies, in USD Million
Table Global Postmenopausal Vaginal Atrophy Treatment Sales Volume 2012-2017, by Companies, in Volume
Table Global Postmenopausal Vaginal Atrophy Treatment Sales Revenue Share, by Companies in 2017, in Volume
Table Postmenopausal Vaginal Atrophy Treatment Demand 2012-2017, by Application, in USD Million
Table Postmenopausal Vaginal Atrophy Treatment Demand 2012-2017, by Application, in Volume
Table Postmenopausal Vaginal Atrophy Treatment Demand Forecast 2018-2023, by Application, in USD Million
Table Postmenopausal Vaginal Atrophy Treatment Demand Forecast 2018-2023, by Application, in Volume
Table Global Postmenopausal Vaginal Atrophy Treatment Market 2012-2017, by Region, in USD Million
Table Global Postmenopausal Vaginal Atrophy Treatment Market 2012-2017, by Region, in Volume
Table Postmenopausal Vaginal Atrophy Treatment Market Forecast 2018-2023, by Region, in USD Million
Table Postmenopausal Vaginal Atrophy Treatment Market Forecast 2018-2023, by Region, in Volume
Figure Postmenopausal Vaginal Atrophy Treatment Industry Chain Structure
Figure Global Postmenopausal Vaginal Atrophy Treatment Market Growth 2012-2017, by Type, in USD Million
Figure Global Postmenopausal Vaginal Atrophy Treatment Market Growth 2012-2017, by Type, in Volume
Figure Global Postmenopausal Vaginal Atrophy Treatment Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Postmenopausal Vaginal Atrophy Treatment Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region